New medical research offers breakthroughs in kidney cancer diagnosis and chemotherapy
New medical research offers breakthroughs in kidney cancer diagnosis and chemotherapy
Medical research is transforming kidney cancer care, moving from a "one-size-fits-all" approach toward precise, personalized medicine.
Furthermore, advanced PET/CT scans and protein biomarkers enable earlier, less invasive detection.
Immunotherapy, such as the pairing of ipilimumab and nivolumab, has shown long-term survival benefits.
Innovations like HIF-2α inhibitors, specifically belzutifan, are helping patients whose cancer has progressed after initial treatments.
Beyond these drugs, emerging cellular therapies, including modified natural killer cells and CAR T-cell treatments, offer hope for resistant tumors.
Ultimately, this progress is largely fueled by clinical trials.
